News

MyChesCo on MSN1d
Arbutus Biopharma Showcases Promising Hepatitis B Research at EASL Congress
Arbutus Biopharma Corporation (Nasdaq: ABUS) announced the acceptance of five abstracts, including a late-breaking study, for ...
Childhood hepatitis B treatment linked to higher odds of long-term virus control
Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the ...
Gastroenterology Advisor1d
Potentially Curative Gene Editing Tx for Chronic HBV Gets Fast Track Status
PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...
World Liver Day: Hepatitis Or Hangover? Spot the Real Reason Behind Your Fatigue
Liver diseases are rising globally, claiming over 2 million lives annually, with viral hepatitis and alcoholic liver disease ...